ThymuSkin Hair Treatment
ThymuSkin Hair Treatment
 |
ThymuSkin Hair Treatment ThymuSkin should be an important part of your hair care routine. It guards against hair loss and dandruff, and activates new hair growth. |
 |
ThymuSkin ®
ThymuSkin® is a topical hair treatment.
Over ten years of clinical studies have been performed on the use of ThymuSkin® as an effective treatment of alopecia androgenetica (Pattern Baldness), diffusa (Hair Loss Over The Whole Scalp and Possible All Parts Of The Body), and areate (Patchy Bladness).
The hair shampoo, treatment (revitalizer) and hair rinse are cosmetics containing thymus gland extract, plant proteins, methyl glucose, elastin, avocado oil, citric acid, pyridoxine, linolic acid, tocopherol acetate, retinyl palmitate, demineralized water, additives and preservatives.
The use of ThymuSkin® in conjunction with chemotherapeutical treatments, has been shown to reduce or completely eliminate associated incidences of alopecia totalis.
The mitigation of alopecia totalis reduces psychological stress on the patient, which can increase the overall effectiveness of treatment.
ThymuSkin® has been shown to be effective in reducing hair loss and creating new hair growth in individuals who experience alopecia androgenetica (Pattern Baldness) and alopecia areata.
Of particular interest is the documentation of no side effects in conjunction with the use of ThymuSkin®. The explanation of the mode of action of ThymuSkin® is a subject of various clinical trials still on-going.
The development of ThymuSkin® could not have occurred without the support of Physicians of the Universities of Heidelberg, Munster- Osnabruck, Hannover and Munich.
Additional research has been provided from the Ludwig-Boltzmann Institute in Darmstadt. Scientific support continues by the German Cancer Research Center (DKFZ), Heidelberg and the Ministry of Science and Technology in Bonn-Bad, Godesberg.
Summary Of The Clinical Effects of ThymuSkin®
The following table presents a comparison of treatment regimes and their effectiveness for the treatment of Alopecia.
Therapy |
Alopecia Types of Baldness |
Sex of Patients |
Duration of Therapy |
Therapy Success (%) |
Author Year |
ThymuSkin® |
androgenetica (Pattern Baldness) |
Women |
12 |
100 |
Mössler /91 |
ThymuSkin® |
androgenetica (Pattern Baldness) |
Men |
12 |
67 |
|
ThymuSkin® |
areata |
Women |
12 |
86 |
|
ThymuSkin® |
areata |
Men |
12 |
86 |
|
ThymuSkin® |
areata totalis universalis |
Both Sexes |
9-24 |
65 |
|
ThymuSkin® |
diffusa |
Women |
12 |
87 |
Klobusch /90 |
ThymuSkin® |
chemotherapy |
Both Sexes |
6 |
32-93 |
Lupke /90 |
ThymuSkin® |
diffusa |
Women |
6 |
73 |
Mössler et al/87 |
Clinical Effects of ThymuSkin®
Clinically Documented Effects of ThymuSkin® on Hair-Loss
Information presented in this overview is the result of clinical investigations on the product - ThymuSkin®. These findings are produced in collaboration with the following investigators:
Vienna City Hospital - Austria
Dept. of Surgery
Ludwig Boltzmann Institute for Clinical Oncology
Prof. Dr. H. Denck, M.D.
Municipal Clinics of Darmstadt
University of Frankfurt
Dermatology Clinic - Director
Prof. Dr. Hagedorn, M.D.
Ruprecht - Karls University of Heidelberg
Gynecological Clinic
Prof. Dr. H.C.V Runnebaum M.D.
(Honorary)
University Clinic of Meunster
Oncology / Surgery
Dr. H. Wilke, M.D.
Medical Clinic of the University of Munich
Dept of Hematology/Oncology
Prof. Dr. Claus O. Kohler
Medical University of Hannover
Dept. of Hematology/Oncology
Dr. H. Wilke, M.D.
University of Osnabrueck, Germany
Chairman of the Division of Pharmacology and Toxicology
Prof. Dr. med. Niels Peter Lüpke M.D.
Hospital of Darmstadt, Germany
Dermatology Clinic
Prof. Dr. Claus O. Köhler M.D.
|
ThymuSkin Hair Treatment ThymuSkin should be an important part of your hair care routine. It guards against hair loss and dandruff, and activates new hair growth. |
|
.gif)
